Kalyan Roy: Immunomodulation after Blood Transfusion
Kalyan Roy, Transfusion Medicine Specialist at Square Hospitals LTD, shared a post on LinkedIn:
“Immunomodulation After Blood Transfusion
Understanding Transfusion-Related Immunomodulation (TRIM)
Blood transfusion is one of the most important life-saving interventions in modern medicine.
However, beyond replacing red cells, platelets, or plasma, transfusion can also influence the recipient’s immune system—a phenomenon known as
Transfusion-Related Immunomodulation (TRIM).
What is TRIM?
TRIM refers to the complex immunological changes that occur following transfusion of allogeneic blood products.
These changes may result in:
- Immune suppression
- Immune activation
- Immune tolerance
- Altered cytokine responses
- Modulation of T-cell and NK-cell function
- Key Mechanisms Behind TRIM
- Allogeneic Leukocyte Exposure
- Interaction with recipient immune cells
- T-cell anergy induction
- Regulatory T-cell (Treg) expansion
- Soluble Bioactive Mediators
- IL-1β, IL-6, IL-8, TNF-α
- Soluble HLA molecules
- Fas Ligand (FasL)
- TGF-β
- Microchimerism
- Persistence of donor leukocytes in recipients
- Promotion of immune tolerance
- Long-term immunological alterations
- Th1 → Th2 Immune Shift
- Reduced cell-mediated immunity
- Enhanced immunosuppressive pathways
- Effects on Innate Immunity
- Reduced neutrophil chemotaxis and phagocytosis
- Altered monocyte/macrophage function
- Decreased Natural Killer (NK) cell activity
- Reduced tumor immune surveillance
- Effects on Adaptive Immunity
- Reduced T-cell proliferation
- Increased T-cell apoptosis
- Expansion of regulatory T-cell populations
- Altered antibody production and humoral immunity
- Potential Clinical Consequences
- Increased susceptibility to infections
- Potential impact on cancer progression and recurrence
- Increased postoperative morbidity
- Longer hospital and ICU stays
- Delayed wound healing
- Possible influence on autoimmune responses
Can Leukoreduction Eliminate TRIM?
While universal leukoreduction significantly reduces:
- Febrile non-hemolytic transfusion reactions
- HLA alloimmunization
- CMV transmission
It does not completely eliminate TRIM, as storage-related bioactive substances and extracellular vesicles may still contribute to immune modulation.
- How Can We Minimize TRIM?
- Patient Blood Management (PBM)
- Restrictive transfusion strategies
- Appropriate component selection
- Universal leukoreduction
- Irradiation when indicated
- Avoidance of unnecessary transfusions
Take-Home Message
Although blood transfusion remains an indispensable therapeutic tool, understanding its immunological consequences is essential for optimizing patient outcomes and advancing transfusion safety.
Every unit transfused carries not only oxygen and hemostatic support—but also potential immunological effects that deserve careful consideration.”
Stay updated with Hemostasis Today.
-
Jun 6, 2026, 17:37Intissar Haddiya: Can Low-Dose Rivaroxaban Improve Cardiovascular Outcomes in Patients with Advanced CKD?
-
Jun 6, 2026, 17:34Stanley Anokye: From Microcytes and Macrocytes to Target Cells
-
Jun 6, 2026, 16:53Leonardo Roever: Can a Simple Cholesterol Ratio Predict Post-Stroke Depression?
-
Jun 6, 2026, 16:21Abdulkader Jamal Eddin: ABO Blood Group, COVID-19 and Early Respiratory Outcomes in Acute PE
-
Jun 6, 2026, 15:26Yuying Zhang: Grateful to Present on CD44 as A Potential Plasma-Independent Alternative to IVIG in ITP
-
Jun 6, 2026, 15:16Don Deyo: Breakthrough Therapy for Post-Stroke Upper Limb Impairment Now Published
-
Jun 6, 2026, 15:14Julianne Chong: Components of Antithrombotic Stewardship Programs from an International Perspective
-
Jun 6, 2026, 15:13Vincent Ten Cate: The Largest Blood-Based EWAS of Atherosclerosis to Date
-
Jun 6, 2026, 14:58Pearla Awad: Liposomal Iron Is Better Tolerated, With Fewer Adverse Effects and Lower Constipation Rates